Article
Vaccines Developed for H5 Highly Pathogenic Avian Influenza in China
1 Oct 2006
Abstract excerpt
Since the first detection of highly pathogenic H5N1 avian influenza virus from sick goose in Guangdong province in China in 1996, scientists in China started to develop vaccines for avian influenza pandemic preparedness. An H5N2 inactivated vaccine was produced from a low pathogenic virus, A/turkey/England/N-28/73, and was used for the buffer zone vaccination in the H5N1 outbreaks in 2004 in China. We also...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
